Number of the records: 1
neuroaspergilóza
SYS d020953 LBL 00000nz--a2200000o--4500 005 20250606214055.6 008 991103|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a C01.150.703.080.537 065 $a C01.150.703.492.750 065 $a C01.207.198.750 065 $a C10.228.228.198.750 066 $a 01 $c 03 150 $a neuroaspergilóza $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x TM $x UR $x VE $x VI $2 slo 550 $7 sllk_us_auth*d003389 $Y Cranial Nerve Diseases $w b $a choroby hlavových nervov 550 $7 sllk_us_auth*d003389 $Y Cranial Nerve Diseases $w p $a choroby hlavových nervov 665 $a 2000 $2 eng 665 $a Aspergillosis (1966-1999) $2 eng 680 9-
$i Infections of the nervous system caused by fungi of the genus ASPERGILLUS, most commonly ASPERGILLUS FUMIGATUS. Aspergillus infections may occur in immunocompetent hosts, but are more prevalent in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. The organism may spread to the nervous system from focal infections in the lung, mastoid region, sinuses, inner ear, bones, eyes, gastrointestinal tract, and heart. Sinus infections may be locally invasive and enter the intracranial compartment, producing MENINGITIS, FUNGAL; cranial neuropathies; and abscesses in the frontal lobes of the brain. (From Joynt, Clinical Neurology, 1998, Ch 27, pp62-3) $2 eng 680 $a coord IM with species (IM) and specific site/dis term (IM) if pertinent $2 eng 750 -2
$a Neuroaspergillosis $2 eng 980 $x M
Number of the records: 1